Php368 - The French Compassionate Use of Medicinal Products Program (2012-2017): Health Technology Assessment and Pricing Implications

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2867
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Patient-Proposed Healthcare Services and Compassionate Use Program：

Iryo To Shakai
2018English

Php87 - Could the French Cohort Atu Program Be the Model Europe Needs to Harmonize Compassionate Use Programs?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – a Health Technology Assessment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Potential Use of Routine Databases in Health Technology Assessment

Health Technology Assessment
MedicineHealth Policy
2005English

Commentary on the Draft Revised Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use

Environmental Sciences Europe
Pollution
2019English

The Pricing Implications of Counterparty Risk for Non-Linear Credit Products

Journal of Credit Risk
EconomicsEconometricsFinance
2005English

Off-Label Use of Medicinal Products - Legal Rules and Practices

Acta Poloniae Pharmaceutica
PharmacologyPharmaceutical Science
2019English

Php205 - Barriers to and Facilitators of the Application of Health Technology Assessment in Medicine Pricing and Reimbursement Policies in Indonesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

From Health Technology Assessment to Health Technology Sustainability

Sustainability
DevelopmentManagementMonitoringEnvironmental ScienceRenewable EnergyEnergy EngineeringLawSustainabilityPlanningPolicyPower Technologythe EnvironmentGeography
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy